Jubilant Pharmova informs about completion of voluntary prepayment

Jubilant Pharmova Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 530019 | NSE: JUBLPHARMA

25 Jun 2024 Evaluate

In continuation to Company’s earlier communication dated June 14, 2024 regarding voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr, Jubilant Pharmova has confirmed that Jubilant Pharma Holdings Inc., USA (‘JPHI’), a wholly owned subsidiary of Jubilant Pharma (‘JPL’), and a wholly owned subsidiary of the Company has completed the voluntary prepayment of above-mentioned term loan on June 24, 2024. The above-mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1835.50
Dr. Reddys Labs.	1171.10
Cipla	1371.45
Lupin	2144.70
Zydus Lifesciences	1153.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.